Wegovy (semaglutide) and Mounjaro (tirzepatide) are brand-name injections. Wegovy is prescribed for weight loss and to lower cardiovascular risks. Mounjaro is approved for type 2 diabetes, and ...

With NovoCare Pharmacy, uninsured patients or eligible patients with commercial insurance who do not have coverage can access all dose strengths of Wegovy, the brand name for semaglutide ...

Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured ...

Novo said its discounted Wegovy would be available in pens of all dosage strengths to uninsured patients or eligible patients with commercial insurance who do not have coverage for obesity ...

Novo Nordisk announced Wednesday the launch of NovoCare Pharmacy, which will offer all dose strengths of Wegovy for $499 a month, for patients without insurance or those with insurance that doesn ...

It now sells vials of all but the two highest-strength doses of the drug through LillyDirect. The lowest dose costs $349 a month and the others cost $499 a month. Novo said its discounted Wegovy ...

With NovoCare Pharmacy, uninsured patients or eligible patients with commercial insurance who do not have coverage can access all dose strengths of Wegovy, the brand name for semaglutide ...

The drugmaker has named its new program NovoCare® Pharmacy, which will sell all dose strengths of Wegovy at $499 per month. According to the company, about 90 percent most patients pay a monthly ...